[1]CurrentPatentAssignee:D.E.SHAWRESEARCHLLC;RELAYTHERAPEUTICSINC-WO2019/183367,2019,A1Locationinpatent:Paragraph0454
[1]CurrentPatentAssignee:SCHROEDINGERLLC;ELILILLY&CO-WO2021/202964,2021,A1Locationinpatent:Paragraph1195
26218-75-7
1052714-48-3
1210419-26-3
1214363-55-9
1214332-73-6
1214386-97-6 | Ethyl 3-bromo-4-(trifluoromethyl)benzoate | AA0014WK | MFCD14698179
1215206-58-8 | 5-Bromo-2-ethoxy-4-methyl-3-nitropyridine | AA00154U | MFCD15143620
121669-70-3 | t-Butyl 4-iodopyrazole-1-carboxylate | AA0015GM | MFCD05663855
1217501-47-7 | 2-Methyl-4-(N-propylsulfamoyl)phenylboronic acid | AA0015QB | MFCD13195668
121859-57-2 | 5,6-Dichloroindole | AA00162A | MFCD27942273
1218791-18-4 | 2-Methoxy-5-nitropyridine-3-boronic acid, pinacol ester | AA001680 | MFCD08063082
122-37-2 | 4-Hydroxydiphenylamine | AA0016GN | MFCD00020142
1221398-11-3 | 6-Chloro-5-iodopyridin-2-amine | AA0016R2 | MFCD20486991
122334-36-5 | 4,N-Dimethyl-n-methoxybenzamide | AA00171W | MFCD02684311
12260-67-2 | Ferrocene, (1-cyclopenten-1-yl)- | AA0017G5 | MFCD00191436